Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Janssen launches HIV drug donation scheme for African children

Janssen launches HIV drug donation scheme for African children

11th December 2013

Janssen has announced the launch of a first-of-its-kind paediatric HIV treatment donation programme in sub-Saharan Africa.

The company will be allying with regional ministries of health to expand the availability of its approved HIV medicines for children and adolescents failing HIV treatment in these underprivileged countries.

Supplies of Prezista and Intelence – including child-friendly formulations – will be provided free of charge to eligible countries with the clinical capacity and willingness to address second and third-line paediatric HIV treatment.

Treatment of HIV among children remains significantly neglected in sub-Saharan Africa. This scheme will provide them with essential medication until they reach the age of 19, at which point they will be transitioned to an adult programme.

Dr Paul Stoffels, chief scientific officer at Johnson and Johnson and worldwide chairman of Janssen, said: "Our vision is that these children receive the HIV treatment and care they need to stay healthy and grow to become healthy, productive young adults."

This comes after the company provided a grant of 355,276 pounds to ensure the advancement of the London-based Global Mental Health Scholarship Fund earlier this week.ADNFCR-8000103-ID-801671122-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.